Interference in Immunoassay
暂无分享,去创建一个
[1] U. Feldt-Rasmussen,et al. Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin, and thyrotropin receptor. , 1996, Clinical chemistry.
[2] J. E. Midgley,et al. Concentrations of free thyroxin and albumin in serum in severe nonthyroidal illness: assay artefacts and physiological influences. , 1990, Clinical chemistry.
[3] L. Demers. Monoclonal antibodies to lutropin: are our immunoassays too specific? , 1991, Clinical Chemistry.
[4] J. E. Rall,et al. An unusual instance of thyroxine-binding by human serum gamma globulin. , 1956, The Journal of clinical endocrinology and metabolism.
[5] G. S. Wilson,et al. Studies of the low dose 'hook' effect in a competitive homogeneous immunoassay. , 1992, Journal of immunological methods.
[6] Endo Yuichi,et al. Use of inorganic salts to minimize serum interference in a sandwich enzyme immunoassay for human growth hormone using Fab'-horseradish peroxidase conjugate. , 1983 .
[7] P. Kirkpatrick,et al. Thyroid-function testing with the TDx: interference from endogenous fluorophore. , 1987, Clinical chemistry.
[8] T. Weber,et al. Endogenous interference in immunoassays in clinical chemistry. A review. , 1990, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[9] R. Ahsan,et al. Serum Binding of Steroid Tracers and its Possible Effects on Direct Steroid Immunoassay , 1995, Annals of clinical biochemistry.
[10] A. Collins. XENOGENEIC ANTIBODIES AND ATOPIC DISEASE , 1988, The Lancet.
[11] J. S. Woodhead,et al. Fenclofenac and Thyroid Function Tests , 1983, Annals of clinical biochemistry.
[12] T. Visser,et al. RAISED TOTAL THYROXINE AND FREE THYROXINE INDEX BUT NORMAL FREE THYROXINE A Serum Abnormality due to Inherited Increased Affinity of Iodothyronines for Serum Binding Protein , 1979, The Lancet.
[13] J. Canick,et al. The effect of smoking in pregnancy on maternal serum alpha‐fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels , 1990, British journal of obstetrics and gynaecology.
[14] P. Oehr,et al. Evidence for interaction of human anti-idiotypic antibodies with CA 125 determination in a patient after radioimmunodetection. , 1990, Clinical chemistry.
[15] C. West,et al. The Long-Term Stability in Whole Blood of 14 Commonly-Requested Hormone Analytes , 1994, Annals of clinical biochemistry.
[16] P. Kenemans,et al. Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assay. , 1990, Clinical chemistry.
[17] J. Gosling. A decade of development in immunoassay methodology. , 1990, Clinical chemistry.
[18] H. van Toor,et al. Free thyroxine assessed with three assays in sera of patients with nonthyroidal illness and of subjects with abnormal concentrations of thyroxine-binding proteins. , 1993, Clinical chemistry.
[19] R. A. Jackson,et al. Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. , 1997, Clinical chemistry.
[20] N. Lawson,et al. Measurement of Urinary Free Cortisol Using the ACS:180 Serum Cortisol Chemiluminescent Immunoassay , 2000, Annals of clinical biochemistry.
[21] J. Ladenson,et al. Endogenous serum antibodies that interfere with a common thyroid hormone uptake assay: characterization and prevalence. , 1994, Clinical chemistry.
[22] M. McConway,et al. Specificity of Two-Site Immunometric Assays , 1991, Annals of clinical biochemistry.
[23] A. Wallace. Analytical Support for the Detection and Treatment of Congenital Adrenal Hyperplasia , 1995, Annals of clinical biochemistry.
[24] G. S. Wilson,et al. Multiple epitope interactions in the two-step sandwich immunoassay. , 1992, Journal of immunological methods.
[25] F. Clark,et al. Spuriously high free thyroxine with the Amerlite MAB FT4 assay. , 1994, Journal of clinical pathology.
[26] C. Migeon,et al. Assay of plasma testosterone during the first six months of life: importance of chromatographic purification of steroids. , 1995, Clinical chemistry.
[27] M. Wheeler,et al. The Role of Testosterone Measurement in the Investigation of Androgen Disorders , 1986, Annals of clinical biochemistry.
[28] C. P. Reilly,et al. Critical Assessment of the Amerlite Free T4 Assay , 1989, Annals of clinical biochemistry.
[29] M H Kroll,et al. Interference with clinical laboratory analyses. , 1994, Clinical chemistry.
[30] César Milstein,et al. Man-made antibodies , 1991, Nature.
[31] E. Nickoloff. Interference in immunoassay. , 1984, Critical reviews in clinical laboratory sciences.
[32] J. E. Midgley,et al. One-step, labeled-antibody assay for measuring free thyroxin. I. Assay development and validation. , 1992, Clinical chemistry.
[33] C. Spencer,et al. Current status and performance goals for serum thyroglobulin assays. , 1996, Clinical chemistry.
[34] I. Laing,et al. Differences in Serum Luteinizing Hormone Measurements by Immunoradiometric Assay Induced by Kinetic Manipulation of Assay Conditions are Dependent on the Endocrine Milieu of Serum , 1996, Annals of clinical biochemistry.
[35] J. Keffer. Preanalytical considerations in testing thyroid function. , 1996, Clinical chemistry.
[36] D. Topliss,et al. Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin. , 1981, The Journal of clinical endocrinology and metabolism.
[37] S. Baudner. Measurement signal versus value in immunoassays for human plasmaproteins. , 1991, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[38] G. S. Wilson,et al. Studies of the 'hook' effect in the one-step sandwich immunoassay. , 1992, Journal of immunological methods.
[39] F. Singer,et al. Measurement of parathyroid hormone. , 1989, Endocrinology and metabolism clinics of North America.
[40] W. Jäger,et al. Human anti-mouse antibodies against OC-125 do not interfere in a CA-125 assay that uses OC-125 and M11 antibodies. , 1993, Clinical chemistry.
[41] R. Ekins. Immunoassay design and optimization , 1991 .
[42] A. Killeen,et al. High-Dose Hook Effect in an Immunoluminometric Thyrotropin Assay: The Open-Faced Sandwich Artefact , 1993, Annals of clinical biochemistry.
[43] N. Yoshikawa,et al. Plasma free thyroxine (FT4) concentrations during hemodialysis in patients with chronic renal failure: effects of plasma non-esterified fatty acids on FT4 measurement. , 1996, Endocrine journal.
[44] Hammer Ej,et al. Increase in serum testosterone following contact with blood cells , 1985 .
[45] T. Lindahl,et al. Chicken antibodies: a tool to avoid interference by complement activation in ELISA. , 1992, Journal of immunological methods.
[46] R. Ekins. Measurement of free hormones in blood. , 1990, Endocrine reviews.
[47] D R Turner,et al. Reappraisal of the causes of the "hook effect" in two-site immunoradiometric assays. , 1982, Analytical biochemistry.
[48] P. Luppa,et al. Effect of sex-hormone-binding globulin on no-extraction immunoassays for testosterone. , 1990, Clinical chemistry.
[49] R. B. Wilcox,et al. Dependence of free thyroxine estimates obtained with equilibrium tracer dialysis on the concentration of thyroxine-binding globulin. , 1992, Clinical chemistry.
[50] J. Nurnberger,et al. Factors that influence radioimmunoassay of human plasma melatonin: a modified column procedure to eliminate interference. , 1993, Biochemical Medicine and Metabolic Biology.
[51] K. Nustad,et al. A sequential binding assay with a working range extending beyond seven orders of magnitude. , 1995, Journal of immunological methods.
[52] R. Swaminathan,et al. The Contribution of Steroids to Digoxin-Like Immunoreactivity in Cord Blood , 1992, Annals of clinical biochemistry.
[53] P. Bodlaender. No SHBG interference with the "Coat-A-Count Total Testosterone" direct RIA kit. , 1990, Clinical chemistry.
[54] W. G. Wood,et al. "Matrix effects" in immunoassays. , 1991, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[55] J. Stockigt,et al. "Unbound analog" radioimmunoassays for free thyroxin measure the albumin-bound hormone fraction. , 1983, Clinical chemistry.
[56] N. Bhagavan,et al. Familial dysalbuminemic hyperthyroxinemia: a study of four probands and the kindred of three. , 1984, Clinical chemistry.
[57] A. Pakarinen,et al. Effects of Drugs on Clinical Laboratory Tests , 1997, Annals of clinical biochemistry.
[58] D Rodbard,et al. Kinetics of two-site immunoradiometric ('sandwich') assays-II. Studies on the nature of the 'high-dose hook effect'. , 1978, Immunochemistry.
[59] J. Cook,et al. Measurement of serum ferritin by a 2-site immunoradiometric assay. , 1974, Analytical biochemistry.
[60] M. F. Stewart,et al. Thyroid Function Tests in Patients with Familial Dysalbuminaemic Hyperthyroxinaemia (FDH) , 1986, Annals of clinical biochemistry.
[61] M. Nahm,et al. Heteroantibody: phantom of the immunoassay. , 1990, Clinical chemistry.
[62] J. M. Brooks,et al. Elimination of "hook-effect" in two-site immunoradiometric assays by kinetic rate analysis. , 1984, Clinical chemistry.
[63] B. Petersen,et al. Quantitation of human anti-mouse antibody in serum by flow cytometry. , 1992, Cytometry.
[64] N. Madry,et al. Measures to overcome HAMA interferences in immunoassays. , 1997, Anticancer research.
[65] L. Boscato,et al. Incidence and specificity of interference in two-site immunoassays. , 1986, Clinical chemistry.
[66] R. Nussenblatt,et al. Intravenous fluorescein interference with clinical laboratory tests. , 1989, American journal of ophthalmology.
[67] R. B. Wilcox,et al. Underestimates of serum free thyroxine (T4) concentrations by free T4 immunoassays. , 1994, The Journal of clinical endocrinology and metabolism.
[68] J. Tuttlebee. Further Experience with Free Thyroxine Assays with Particular Reference to Pregnancy , 1982, Annals of clinical biochemistry.
[69] I. Vermes,et al. Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalization with WHO standard. , 1991, Clinical chemistry.
[70] K. Yasuda,et al. Prevalence of thyroid hormone autoantibodies in healthy subjects , 1994, Clinical endocrinology.
[71] H. Ozaki,et al. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer. , 1995, Journal of immunological methods.
[72] R. John,et al. Antibody Interference in a Two-Site Immunometnc Assay for Thyrotrophin , 1989, Annals of clinical biochemistry.
[73] E. Slaats,et al. Interference of sex-hormone binding globulin in the "Coat-A-Count" testosterone no-extraction radioimmunoassay. , 1987, Clinical chemistry.
[74] C. O’Farrelly,et al. IgA rheumatoid factor and IgG dietary protein antibodies are associated in rheumatoid arthritis. , 1989, Immunological investigations.
[75] M. Worwood,et al. Antigen Binding in the Two-Site Immunoradiometric Assay for Serum Ferritin: The Nature of the Hook Effect , 1984, Annals of clinical biochemistry.
[76] R. Heimer,et al. Specificity of IgM antibodies to pooled human F(ab')2 fragments. , 1984, Immunological communications.
[77] N. Bizzaro,et al. Pitfalls in measuring lutropin by two-site immunoassay with monoclonal antibodies against the intact molecule. , 1992, Clinical chemistry.
[78] S. Morrison,et al. Production and characterization of genetically engineered antibody molecules. , 1988, Clinical chemistry.
[79] L. Kricka,et al. Interference by human anti-mouse antibody in two-site immunoassays. , 1990, Clinical chemistry.
[80] D. Goldenberg,et al. Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen. , 1989, Clinical chemistry.
[81] J. Sgouris. Limitations of the radioimmunoassay for hepatitis B antigen (HB Ag). , 1973, The New England journal of medicine.
[82] R. Hähnel,et al. Investigation of sex-hormone binding globulin interference in direct radioimmunoassays for testosterone and estradiol. , 1989, Clinical chemistry.
[83] S. Bock,et al. A study of serum antibodies to isolated milk proteins and ovalbumin in infants and children , 1977, Clinical allergy.
[84] C. Cambiaso,et al. Particle counting immunoassay (PACIA). , 1981, Methods in enzymology.
[85] R. Lamerz,et al. Value of HAMA--determination in clinical practice--an overview. , 1997, Anticancer research.
[86] R. B. Wilcox,et al. Analytical performance of free and total thyroxine assays. , 1996, Clinical chemistry.
[87] N. Amino,et al. Digoxin immunoassay that avoids cross-reactivity from Chinese medicines. , 1995, Clinical chemistry.
[88] M. McConway,et al. Discrepancies in hFSH Measurements by Two-Site IRMA in the Ovulatory Phase of the Menstrual Cycle , 1992, Annals of clinical biochemistry.
[89] T. Mckenna,et al. Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies , 1994, Clinical endocrinology.
[90] Saris Ne. Provisional recommendation on quality control in clinical chemistry. , 1977, Clinica chimica acta; international journal of clinical chemistry.
[91] L. Bartalena,et al. Thyroid hormone transport proteins. , 1993, Clinics in laboratory medicine.
[92] W. Jeffcoate,et al. RADIOIMMUNOASSAY ARTIFACT ASSOCIATED WITH CIRCULATING ANTI‐RABBIT ANTIBODIES , 1988, Clinical endocrinology.
[93] K. Ashwell,et al. Serum Free Thyroxine Concentrations in Subjects with High Circulating Levels of Thyroxine-Binding Globulin , 1983, Annals of clinical biochemistry.
[94] M. Zweig,et al. Analytical interference caused by incompletely clotted serum specimens. , 1994, Clinical chemistry.
[95] J. Ghali,et al. A new interference in some digoxin assays: Anti‐murine heterophilic antibodies , 1996, Clinical pharmacology and therapeutics.
[96] L. Cole,et al. Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free beta-subunit. , 1992, Clinical chemistry.
[97] S. Refetoff. Inherited thyroxine-binding globulin abnormalities in man. , 1989, Endocrine reviews.
[98] J. Highton,et al. A solid-phase enzyme immunoassay for C-reactive protein: clinical value and the effect of rheumatoid factor. , 1984, Journal of immunological methods.